FDA inspection

Bioreliance Ltd.: FDA inspection ending Mar 17, 2021

FDA inspection 1202961 · Voluntary Action Indicated (VAI) · Glasgow

Key facts

Inspection ID 1202961
Firm Bioreliance Ltd.
FEI number 3005343934
Address Todd Campus, West Of Scotland Science Park
City Glasgow
Country United Kingdom
Fiscal year 2021
Inspection end date Mar 17, 2021
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections